Review Article| Volume 69, ISSUE 1, P149-162, August 2022

Genital Herpes Simplex Virus—An Updated Review


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rechenchoski D.Z.
        • Faccin-Galhardi L.C.
        • Linhares R.E.C.
        • et al.
        Herpesvirus: an underestimated virus.
        Folia Microbiologica. 2017; 62
        • Harris K.D.
        Herpes Simplex Virus Keratitis.
        Home Healthc Now. 2019; 37
        • Bernstein D.I.
        • Flechtner J.B.
        • McNeil L.K.
        • et al.
        Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.
        Vaccine. 2019; 37
        • McQuillan G.
        • Kruszon-Moran D.
        • Flagg E.W.
        • et al.
        Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14-49: United States, 2015-2016.
        NCHS data brief. 2018; : 1-8
        • Chemaitelly H.
        • Nagelkerke N.
        • Omori R.
        • et al.
        Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States.
        PLoS One. 2019; 14
        • Spicknall I.H.
        • Flagg E.W.
        • Torrone E.A.
        Estimates of the Prevalence and Incidence of Genital Herpes, United States, 2018.
        Sex Transm Dis. 2021; 48
        • Kreisel K.M.
        • Spicknall I.H.
        • Gargano J.W.
        • et al.
        Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018.
        Sex Transm Dis. 2021; 48
        • Groves M.J.
        Genital herpes: A review.
        Am Fam Physician. 2016; 93: 928-934
        • Roberts C.M.
        • Pfister J.R.
        • Spear S.J.
        Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.
        Sex Transm Dis. 2003; 30
      1. American College Health Association. American College Health Association-National College Health Assessment. Reference Group Executive Summary.; 2020.

        • Bernstein D.I.
        • Bellamy A.R.
        • Hook E.W.
        • et al.
        Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.
        Clin Infect Dis. 2013; 56
        • Mustafa M.
        • Illzam E.M.
        • Muniandy R.K.
        • et al.
        Herpes simplex virus infections, Pathophysiology and Management.
        IOSR J Dental Med Sci. 2016; 15: 85-91
      2. Whitley R, Kimberlin DW, Prober CG. Pathogenesis and disease. In: Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 32.

        • Sauerbrei A.
        Herpes Genitalis: Diagnosis, Treatment and Prevention.
        Geburtshilfe Frauenheilkd. 2016; 76: 1310-1317
        • Whitley R.J.
        in: Baron S. Medical microbiology. 4th edition. University of Texas Medical Branch at Galveston, Galveston (TX)1996: 1996 (Chapter 68. Available From)
        • Berger J.R.
        • Houff S.
        Neurological Complications of Herpes Simplex Virus Type 2 Infection.
        Arch Neurol. 2008; 65
        • Johnston C.
        • Corey L.
        Current concepts for genital herpes simplex virus infection: Diagnostics and pathogenesis of genital tract shedding.
        Clin Microbiol Rev. 2015; 29: 149-161
        • Workowski K.A.
        • Bachmann L.H.
        • Chan P.A.
        • et al.
        Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports.
        . 2021; 70
        • Nath P.
        • Kabir M.A.
        • Doust S.K.
        • et al.
        Diagnosis of herpes simplex virus: Laboratory and point-of-care techniques.
        Infect Dis Rep. 2021; 13: 518-539
        • van Wagoner N.J.
        • Hook E.W.
        Herpes diagnostic tests and their use.
        Curr Infect Dis Rep. 2012; 14: 175-184
      3. Singh A, Preiksaitis J, Frcpc MD, Romanowski B. The Laboratory Diagnosis of Herpes Simplex Virus Infections. Vol 16.

      4. Strick LB, Wald A. Diagnostics for Herpes Simplex Virus Is PCR the New Gold Standard? Vol 10.; 2006.

      5. Morbidity and Mortality Weekly Report.
        MMWR Surveill Summ. 2021; 70
        • Bibbins-Domingo K.
        • Grossman D.C.
        • Curry S.J.
        • et al.
        Serologic screening for genital herpes infection: US preventive services task force recommendation statement.
        JAMA. 2016; 316: 2525-2530
        • Mindel A.
        Psychological and psychosexual implications of herpes simplex virus infections.
        Scand J Infect Dis Suppl. 1996; 100: 27-32
      6. Mindel A, Marks C. Psychological Symptoms Associated with Genital Herpes Virus Infections Epidemiology and Approaches to Management. Vol 19.; 2005.

        • Merin A.
        • Pachankis J.E.
        The psychological impact of genital herpes stigma.
        J Health Psychol. 2011; 16: 80-90
        • Leone P.
        Chapter 14. Genital Herpes.
        in: Klausner J.D. Hook E.W. CURRENT diagnosis & treatment of sexually transmitted diseases. The McGraw-Hill Companies, New York2007: 84-90 (Available at:)
        • Nath A.K.
        • Thappa D.M.
        Newer trends in the management of genital herpes.
        Indian J Dermatol Venereol Leprol. 2009; 75
        • Grund J.M.
        • Bryant T.S.
        • Jackson I.
        • et al.
        Association between male circumcision and women’s biomedical health outcomes: a systematic review.
        Lancet Glob Health. 2017; 5
        • Celum C.
        • Morrow R.A.
        • Donnell D.
        • et al.
        Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: A subgroup analysis of a randomized trial.
        Ann Intern Med. 2014; 161
        • Karim S.S.A.
        • Kashuba A.D.
        • Werner L.
        • et al.
        Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: Implications for HIV prevention in women.
        Lancet. 2011; 378
        • Belshe R.B.
        • Leone P.A.
        • Bernstein D.I.
        • et al.
        Efficacy Results of a Trial of a Herpes Simplex Vaccine.
        N Engl J Med. 2012; 366
        • Sauerbrei A.
        Optimal management of genital herpes: Current perspectives.
        Infect Drug Resist. 2016; 9
        • Parks G.
        Genital Herpes.
        in: Nelson A.L. Woodward J. Wysocki S. Sexually transmitted diseases: a practical guide for primary care. Humana Press, Totowa(NJ)2006: 47-70
        • Kimberlin D.W.
        Herpes Simplex Virus Infections of the Newborn.
        Semin Perinatol. 2007; 31
        • Pinninti S.G.
        • Kimberlin D.W.
        Maternal and neonatal herpes simplex virus infections.
        Am J Perinatol. 2013; 30
        • Brown Z.A.
        Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.
        Pediatr Infect Dis J. 1991; 10
        • Johnston C.
        • Magaret A.
        • Selke S.
        • et al.
        Herpes simplex virus viremia during primary genital infection.
        J Infect Dis. 2008; 198
        • Corey L.
        • Wald A.
        Maternal and Neonatal Herpes Simplex Virus Infections.
        N Engl J Med. 2009; 361
      7. ACOG. PB 220: Management of Genital Herpes in Pregnancy.
        Obstet Gynecol. 2020; 133
        • Hollier L.M.
        • Wendel G.D.
        Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
        Cochrane Database Syst Rev. 2008; 1
        • Vontver L.A.
        • Hickok D.E.
        • Brown Z.
        • et al.
        Recurrent genital herpes simplex virus infection in pregnancy: Infant outcome and frequency of asymptomatic recurrences.
        Am J Obstet Gynecol. 1982; 143